HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTCBB: PWRM, https://www.power3medical.com), a leading proteomics company specializing in the development and commercialization of diagnostic tests for the early detection of breast cancer and neurodegenerative diseases, filed a U.S. Utility Patent application for forty-seven protein biomarkers of neurodegenerative disease in human blood serum.
